Literature DB >> 16736033

A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci.

Jane Winantea1, My Ngo Hoang, Stefanie Ohlraun, Marcella Rietschel, Sven Cichon, Peter Propping, Markus M Nöthen, Jan Freudenberg, Yun Freudenberg-Hua.   

Abstract

In order to explore the role of noncoding variants in the genetics of schizophrenia, we sequenced 27 kb of noncoding DNA from the gene loci RAC-alpha serine/threonine-protein kinase (AKT1), brain-derived neurotrophic factor (BDNF), dopamine receptor-3 (DRD3), dystrobrevin binding protein-1 (DTNBP1), neuregulin-1 (NRG1) and regulator of G-protein signaling-4 (RGS4) in 37 schizophrenia patients and 25 healthy controls. To compare the allele frequency spectrum between the two samples, we separately computed Tajima's D-value for each sample. The results showed a smaller Tajima's D-value in the case sample, pointing to an excess of rare variants as compared to the control sample. When randomly permuting the affection status of sequenced individuals, we observed a stronger decrease of Tajima's D in 2400 out of 100,000 permutations, corresponding to a P-value of 0.024 in a one-sided test. Thus, rare variants are significantly enriched in the schizophrenia sample, indicating the existence of disease-related sequence alterations. When categorizing the sequenced fragments according to their level of human-rodent conservation or according to their gene locus, we observed a wide range of diversity parameter estimates. Rare variants were enriched in conserved regions as compared to nonconserved regions in both samples. Nevertheless, rare variants remained more common among patients, suggesting an increased number of variants under purifying selection in this sample. Finally, we performed a heuristic search for the subset of gene loci, which jointly produces the strongest difference between controls and cases. This showed a more prominent role of variants from the loci AKT1, BDNF and RGS4. Taken together, our approach provides promising strategy to investigate the genetics of schizophrenia and related phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736033     DOI: 10.1038/sj.ejhg.5201664

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  4 in total

1.  Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil Bamne; Joel Wood; Michael E Talkowski; Karoly Mirnics; Pat Levitt; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-05-21       Impact factor: 9.306

2.  Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.

Authors:  Julio Licinio; Chuanhui Dong; Ma-Li Wong
Journal:  Arch Gen Psychiatry       Date:  2009-05

3.  Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.

Authors:  John A Lees; Bart Ferwerda; Philip H C Kremer; Nicole E Wheeler; Mercedes Valls Serón; Nicholas J Croucher; Rebecca A Gladstone; Hester J Bootsma; Nynke Y Rots; Alienke J Wijmega-Monsuur; Elisabeth A M Sanders; Krzysztof Trzciński; Anne L Wyllie; Aeilko H Zwinderman; Leonard H van den Berg; Wouter van Rheenen; Jan H Veldink; Zitta B Harboe; Lene F Lundbo; Lisette C P G M de Groot; Natasja M van Schoor; Nathalie van der Velde; Lars H Ängquist; Thorkild I A Sørensen; Ellen A Nohr; Alexander J Mentzer; Tara C Mills; Julian C Knight; Mignon du Plessis; Susan Nzenze; Jeffrey N Weiser; Julian Parkhill; Shabir Madhi; Thomas Benfield; Anne von Gottberg; Arie van der Ende; Matthijs C Brouwer; Jeffrey C Barrett; Stephen D Bentley; Diederik van de Beek
Journal:  Nat Commun       Date:  2019-05-15       Impact factor: 14.919

4.  Genomic Assessment of Cancer Susceptibility in the Threatened Catalina Island Fox (Urocyon littoralis catalinae).

Authors:  Sarah A Hendricks; Julie L King; Calvin L Duncan; Winston Vickers; Paul A Hohenlohe; Brian W Davis
Journal:  Genes (Basel)       Date:  2022-08-22       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.